of the Intergroupe Francophone du Myélome Genetic abnormalities and survival in multiple myeloma: the experience

Marta Chesi, P. Leif Bergsagel, Oluwatoyin O. Shonukan, Maria Luisa Martelli, Leslie A. Brents, Theresa Chen, Evelin Schröck, Thomas Ried, W. Michael Kuehl, Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma Blood. ,vol. 91, pp. 4457- 4463 ,(1998) , 10.1182/BLOOD.V91.12.4457

B Barlogie, R Alexanian, D Dixon, L Smith, L Smallwood, K Delasalle, Prognostic implications of tumor cell DNA and RNA content in multiple myeloma Blood. ,vol. 66, pp. 338- 341 ,(1985) , 10.1182/BLOOD.V66.2.338.338

GW Dewald, RA Kyle, GA Hicks, PR Greipp, The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis Blood. ,vol. 66, pp. 380- 390 ,(1985) , 10.1182/BLOOD.V66.2.380.380

Marta Chesi, Elena Nardini, Robert S.C. Lim, Kerrington D. Smith, W. Michael Kuehl, P. Leif Bergsagel, The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3 and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts Blood. ,vol. 92, pp. 3025- 3034 ,(1998) , 10.1182/BLOOD.V92.9.3025

Philip R. Greipp, Gordon W. Dewald, Scott A. Van Wier, S. Vincent Rajkumar, Martin M. Oken, Emily A. Blood, David Harrington, Kimberly J. Henderson, Neil E. Kay, Brian Van Ness, Rafael Fonseca, Richard J. Bailey, Biological and Prognostic Significance of Interphase Fluorescence in Situ Hybridization Detection of Chromosome 13 Abnormalities (Δ13) in Multiple Myeloma: An Eastern Cooperative Oncology Group Study Cancer Research. ,vol. 62, pp. 715- 720 ,(2002)

A. Keith Stewart, Rafael Fonseca, Prognostic and Therapeutic Significance of Myeloma Genetics and Gene Expression Profiling Journal of Clinical Oncology. ,vol. 23, pp. 6339- 6344 ,(2005) , 10.1200/JCO.2005.05.023

Nicole Véronique Smadja, Christian Bastard, Christophe Brigaudeau, Dominique Leroux, Christophe Fruchart, Hypodiploidy is a major prognostic factor in multiple myeloma Blood. ,vol. 98, pp. 2229- 2238 ,(2001) , 10.1182/BLOOD.V98.7.2229

P. Leif Bergsagel, W. Michael Kuehl, Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma Journal of Clinical Oncology. ,vol. 23, pp. 6333- 6338 ,(2005) , 10.1200/JCO.2005.05.021

Wilfrid Jaksic, Suzanne Trudel, Hong Chang, Young Trieu, Xi Qi, Joseph Mikhael, Donna Reece, Christine Chen, A. Keith Stewart, Clinical Outcomes in t(4;14) Multiple Myeloma: A Chemotherapy-Sensitive Disease Characterized by Rapid Relapse and Alkylating Agent Resistance Journal of Clinical Oncology. ,vol. 23, pp. 7069- 7073 ,(2005) , 10.1200/JCO.2005.17.129

C S Debes-Marun, G W Dewald, S Bryant, E Picken, R Santana-Dávila, N González-Paz, J M Winkler, R A Kyle, M A Gertz, T E Witzig, A Dispenzieri, M Q Lacy, S V Rajkumar, J A Lust, P R Greipp, R Fonseca, Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia. ,vol. 17, pp. 427- 436 ,(2003) , 10.1038/SJ.LEU.2402797